The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease
| dc.centro | Facultad de Medicina | |
| dc.contributor.author | Romero-Fernandez, Wilber | |
| dc.contributor.author | Taura, Jaume J. | |
| dc.contributor.author | Crans, René A. J. | |
| dc.contributor.author | Lopez-Cano, Marc | |
| dc.contributor.author | Fores-Pons, Ramon | |
| dc.contributor.author | Narváez, Manuel | |
| dc.contributor.author | Carlsson, Jens | |
| dc.contributor.author | Ciruela, Francisco | |
| dc.contributor.author | Fuxe, Kjell | |
| dc.contributor.author | Borroto-Escuela, Dasiel O. | |
| dc.date.accessioned | 2026-01-29T11:03:19Z | |
| dc.date.issued | 2022-07-12 | |
| dc.departamento | Fisiología Humana, Histología Humana, Anatomía Patológica y Educación Físico Deportiva | |
| dc.description.abstract | The adenosine A2A receptor (A2AR), dopamine D2 receptor (D2R) and metabotropic glutamate receptor type 5 (mGluR5) form A2AR-D2R-mGluR5 heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A2AR protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D2R-mGluR5 heteromeric component of the A2AR-D2R-mGluR5 complex in vitro and in vivo. The A2AR and mGluR5 protomers interact and modulate D2R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A2AR in HEK293T cells co-expressing D2R and mGluR5 resulted in a significant and marked increase in the formation of the D2R-mGluR5 heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D2R (D2RKi High) values was found upon cotreatment with the mGluR5 and A2AR agonists in the cells expressing A2AR, D2R and mGluR5 with a significant effect observed also with the mGluR5 agonist alone compared to cells expressing only D2R and mGluR5. In cells co-expressing A2AR, D2R and mGluR5, stimulation of the cells with an mGluR5 agonist like or D2R antagonist fully counteracted the D2R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR5 and D2R. In agreement, the mGluR5-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A2AR knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR5 and A2AR in enhancing D2R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes. | |
| dc.description.sponsorship | Karolinska Institutet (Open access funding) | |
| dc.description.sponsorship | Swedish Research Council (Vetenskapsrådet) | |
| dc.description.sponsorship | ParkinsonFonden | |
| dc.description.sponsorship | Hjärnfonden | |
| dc.description.sponsorship | Karolinska Institutet Forskningsstiftelser | |
| dc.description.sponsorship | Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI) – EMERGIA (Junta de Andalucía) | |
| dc.description.sponsorship | Olle Engkvists Stiftelse | |
| dc.description.sponsorship | MCIN/AEI (Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación, España) | |
| dc.description.sponsorship | FEDER (Fondo Europeo de Desarrollo Regional) | |
| dc.description.sponsorship | CERCA Programme (Generalitat de Catalunya) / IDIBELL (institutional support) | |
| dc.identifier.citation | Romero-Fernandez, W., Taura, J.J., Crans, R.A.J. et al. The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease. Mol Neurobiol 59, 5955–5969 (2022). https://doi.org/10.1007/s12035-022-02946-9 | |
| dc.identifier.doi | 10.1007/s12035-022-02946-9 | |
| dc.identifier.issn | 0893-7648 | |
| dc.identifier.uri | https://hdl.handle.net/10630/45021 | |
| dc.language.iso | eng | |
| dc.publisher | Springer | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Swedish_Research_Council//2019-01022/SE/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Swedish_Research_Council//62X-00715-50-3/SE/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Swedish_Research_Council//2017-4676/SE/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Hjarnfonden//F02018-0286/SE/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Hjarnfonden//F02019-0296/SE/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/PAIDI/EMERGIA/2020-39318/ES/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/MCIN/AEI/PID2020-118511RB-I00/ES/// | |
| dc.relation.projectID | info:eu-repo/grantAgreement/Generalitat_de_Catalunya/SGR/2017SGR1604/ES/// | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Parkinson, Enfermedad de | |
| dc.subject | Dopamina - Receptores | |
| dc.subject.other | Heteroreceptor complexes | |
| dc.subject.other | Dopamine D2R receptor | |
| dc.subject.other | Adenosine A2A receptor | |
| dc.subject.other | Parkinson’s Disease | |
| dc.subject.other | Metabotropic glutamate receptor subtype 5 (mGluR5) | |
| dc.subject.other | Oligomerization | |
| dc.title | The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1

